BRIEF-Lilly CEO says prepared for all scenarios in case of ACA repeal
January 31, 2017 at 13:09 PM EST
* Lilly CEO says if all Alimta patents are upheld, drug will be exclusively marketed in the U.S. till 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.